ATF4 and neoplasm: The results may suggest that the PD1/PDL1 reverse signaling may activate the eIF2α/ATF4 pathway in tumor surrounding cells [27] and IRF1 may be active in regulating PDL1 expression in the tumor tissue [7–9].